Antimicrobial resistance Archives

Iterum Therapeutics antibiotics series b fundraising

News and Trends 19 May 2017

Irish Biotech developing New Antibiotics attracts €58M in Series B Round

Iterum Therapeutics has raised €58M to fund Phase III and bring a new antibiotic to a market where innovation is lacking. Iterum Therapeutics is a biotech based in Dublin that develops new antibiotics with the aim of combating the superbug crisis. The company has just raised €58M ($65M) in Series B to fund Phase III […]

May 19, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

hypermutation biofuels antimicrobial resistance cancer

News and Trends 9 May 2017

Hypermutation could be the Key to Biofuels – and Antibiotic Resistance

Instead of taking a spa vacation, stressed out bacteria start mutating their DNA fast. This nearly suicidal behavior can yield a lucky survivor in nature. For us, it could mean new strategies for biofuel production and fighting antibiotic resistance, researchers say. Researchers from the Centre of Microbial and Plant Genetics at KU Leuven, in Belgium, are shining […]

May 9, 2017 - 2 minutesmins - By Denise Neves Gameiro

In Depth 9 May 2017

Rise of the Superbugs: How is Biotech Fighting Antibiotic Resistance?

Fewer antibiotics are produced as development costs rise. We reached out to a few companies addressing the serious issue of antibiotic resistance. Antibiotic resistance is one of the greatest threats to our societies and health systems, and the number of antibiotic-resistant bacteria is growing at a disquieting rate. The estimated number of people killed by […]

May 9, 2017 - 8 minutesmins - By External Contributor

News and Trends 5 May 2017

Forget Chemical Synthesis, Yeast can Now Synthesize Complex Antibiotics

A new study presents a novel synthetic biology approach for antibiotic synthesis in yeast that could tackle the huge challenge of antibiotic resistance. Scientists at Imperial College London have hacked their way into introducing complex biosynthesis pathways in the baker’s yeast Saccharomyces cerevisiae. In particular, they focused on the production of non-ribosomal peptides (Nrp), a group of […]

May 5, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 4 May 2017

Parent Bacteria Resist Antibiotics Better than their Offspring

According to a new study, a phenomenon known as biased inheritance protects older bacteria from the wrath of antibiotics in low concentrations. Older bacteria in a mixed population of dividing E. coli cells inherit a larger number of drug-expelling membrane proteins and pump out antibiotics better than their younger counterparts in the presence of low […]

May 4, 2017 - 3 minutesmins - By External Contributor

News and Trends 22 Apr 2017

Art Made with CRISPR Aims to Raise Awareness of Antibiotic Resistance

Anna Dumitriu’s latest bioart piece is a historic dress carrying bacteria genetically modified using CRISPR and opens the debate on antibiotic resistance. A wartime women’s suit is the canvas where Anna Dumitriu paints the history of antibiotics. The holes and stains in the suit are patched and embroidered with silk that has been dyed with E. […]

April 22, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

fungi secondary metabolites genome sequencing

News and Trends 21 Apr 2017

Fungi Genomes could be a Gold Mine of New Antibiotics

Good old Penicillium still has a lot more tricks upon its sleeve: Swedish researchers see its potential as a gold mine for new antibiotics. The genomic analysis of Penicillium species represents a potential gold mine for new bioactive compounds, or improved versions of those we already use. Published recently in Nature Microbiology, the work was carried at Chalmers University […]

April 21, 2017 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 12 Apr 2017

Swiss Pharma Clears €37M Funding to Develop a New Class of Antibiotics

Swiss Polyphor has closed a €37M (CHF40M) private funding round to finance the development of its most advanced candidate tackling antibiotic resistances. Polyphor is a clinical stage pharma developing a specific class of so called ‘macrocyclic drugs‘, which are chemically defined by a ring structure. The company’s pipeline is covering a broad range of diseases such as […]

April 12, 2017 - 3 minutesmins - By Melanie De Almeida

News and Trends 6 Apr 2017

This New Biotech counts with the Largest Antibiotic Resistance Database

Curetis has launched Ares Genetics, a company that will use the biggest antibiotic resistance genetic database to advance the diagnose of infections. Ares Genetics, the new subsidiary of Curetis, will investigate the genetic foundation of antibiotic resistance to develop new approaches for the rapid diagnose of specific resistance in patients with infections, as well as tools to […]

April 6, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Research Biosensor Chip Bacterial Infections 1

News and Trends 24 Mar 2017

New Biochips Quickly Identify the Best Antibiotic for each Bacterial Infection

Scientists from Israel have piloted a new silicon biosensor chip that can rapidly identify the best antibiotics for treating a bacterial infection. Antibiotic resistance makes up one of the major health challenges of the 21st century. Some of the major causes of the increasing numbers of resistant bacterial strains are overuse of antibiotics and mistreatment of infections. […]

March 24, 2017 - 3 minutesmins - By Melanie De Almeida

News and Trends 11 Mar 2017

You Can Watch Fleming’s Original Penicillin Culture in Oxford!

The Museum of the History of Science in Oxford is hosting an exhibition on the history of penicillin and the current challenges of antibiotic resistance featuring the first culture used to extract the antibiotic. The discovery of penicillin by Alexander Fleming in the early 20th century changed the world of medicine. Antibiotics have saved millions […]

March 11, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 7 Mar 2017

A New Transatlantic Partnership takes on Antibiotic Resistance

The Swiss biotech BioVersys and the US company Aptuit have entered a new collaboration to target antibiotic resistances. BioVersys, based in Basel, is developing small molecules that interfere with bacterial resistance mechanisms. Its current research is focused on nosocomial infections (hospital infections) and tuberculosis. To advance the development of compounds against novel targets identified by BioVersys, the company has […]

March 7, 2017 - 2 minutesmins - By Melanie De Almeida

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us